Cannabinoids Significantly Reduced Dystonia in Seven Huntington's Disease Patients
Seven patients with early-onset Huntington's disease showed significant improvement in motor symptoms, particularly dystonia, after starting cannabinoid treatment, with additional benefits in behavior and daily functioning.
Quick Facts
What This Study Found
UHDRS motor scores improved from 70.9 to 60.6 (mean change 10.3 points, 95% CI 6.0-14.6, p=0.018). The dystonia subscore improved from 12.3 to 8.0 (mean change 4.3 points, 95% CI 2.3-6.3, p=0.018). Patients also showed improvements in gait, fine motor skills, weight gain, and behavior.
Key Numbers
Motor score improved by 10.3 points (from 70.9 to 60.6). Dystonia subscore improved by 4.3 points (from 12.3 to 8.0). Both improvements were statistically significant (p=0.018).
How They Did This
Case series of seven early-onset HD patients assessed with the Unified Huntington's Disease Rating Scale before and after starting cannabinoids, with no other medication changes during the observation period.
Why This Research Matters
Treatment options for dystonia in Huntington's disease are extremely limited. This case series provides evidence that cannabinoids may fill a significant therapeutic gap for one of HD's most debilitating symptoms.
The Bigger Picture
Dystonia has high prevalence in HD but is often overshadowed by chorea in research. These findings suggest cannabinoids may be particularly effective for the dystonic component, which can be more disabling than chorea in many patients.
What This Study Doesn't Tell Us
Small case series without placebo control or blinding. All patients had early-onset HD, which may differ from typical adult-onset HD. No standardized cannabinoid formulation or dose across patients.
Questions This Raises
- ?Would these results hold up in a controlled trial?
- ?Do cannabinoids work for dystonia in adult-onset HD as well?
- ?What cannabinoid formulation and dose is optimal?
- ?How long do the benefits last?
Trust & Context
- Key Stat:
- Dystonia subscore improved by 35% (from 12.3 to 8.0, p=0.018) with cannabinoid treatment.
- Evidence Grade:
- Preliminary - uncontrolled case series with only seven patients, though results were statistically significant.
- Study Age:
- Published in 2018.
- Original Title:
- Cannabinoids for Treatment of Dystonia in Huntington's Disease.
- Published In:
- Journal of Huntington's disease, 7(2), 167-173 (2018)
- Authors:
- Saft, Carsten, von Hein, Sarah Maria, Lücke, Thomas, Thiels, Charlotte, Peball, Marina, Djamshidian, Atbin, Heim, Beatrice, Seppi, Klaus
- Database ID:
- RTHC-01819
Evidence Hierarchy
Describes what happened to one person or a small group.
What do these levels mean? →Frequently Asked Questions
Can cannabis help with Huntington's disease?
This case series found that cannabinoids significantly reduced dystonia and improved overall motor function in seven early-onset HD patients. Motor scores improved by about 15%, and patients gained additional benefits in gait, behavior, and weight.
Does cannabis treat dystonia?
In this small study of Huntington's disease patients, cannabinoids reduced dystonia scores by 35%. Previous reports have also described cannabinoid benefits for dystonia from other causes, but controlled trials are needed.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-01819APA
Saft, Carsten; von Hein, Sarah Maria; Lücke, Thomas; Thiels, Charlotte; Peball, Marina; Djamshidian, Atbin; Heim, Beatrice; Seppi, Klaus. (2018). Cannabinoids for Treatment of Dystonia in Huntington's Disease.. Journal of Huntington's disease, 7(2), 167-173. https://doi.org/10.3233/JHD-170283
MLA
Saft, Carsten, et al. "Cannabinoids for Treatment of Dystonia in Huntington's Disease.." Journal of Huntington's disease, 2018. https://doi.org/10.3233/JHD-170283
RethinkTHC
RethinkTHC Research Database. "Cannabinoids for Treatment of Dystonia in Huntington's Disea..." RTHC-01819. Retrieved from https://rethinkthc.com/research/saft-2018-cannabinoids-for-treatment-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.